Defining patient-centered amyloid PET thresholds for the onset of tauopathy in Alzheimer’s disease
Published in Alzheimer's & Dementia, 2026 (Online Early View), 2026
This study establishes patient-centered amyloid PET thresholds for the onset of tauopathy, demonstrating that age and sex significantly influence the amyloid-to-tauopathy transition in Alzheimer’s disease.
Recommended citation: Zhu, Z., Steward, A., Dehsarvi, A., Roemer-Cassiano, S. N., Dewenter, A., Hirsch, F., Frontzkowski, L., Pescoller, J., Klonowski, M., Gnörich, J., Pontecorvo, M. J., Shcherbinin, S., Schöll, M., Buckley, R., Ossenkoppele, R., van der Flier, W. M., & Franzmeier, N. (2026). Defining patient-centered amyloid PET thresholds for the onset of tauopathy in Alzheimer's disease. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71064
Download Paper